Navigation Links
Roche announces termination of 2013 Development, Commercialization and License Agreement with Pacific Biosciences
Date:12/15/2016

PLEASANTON, Calif., Dec. 15, 2016 /PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that it has officially notified Pacific Bioscience (PacBio) of its intention to terminate its agreement and efforts to develop a sequencing instrument for use in the clinical research and clinical market using their Single Molecule, Real-Time (SMRT®) technology.

With this termination, Roche no longer retains rights to this technology and PacBio is free to approach any market segments with their SMRT technology.

"As a result of this decision we will have greater focus on our internal development efforts and drive our long term strategy which is to be a leader in clinical diagnostic sequencing," said Neil Gunn, Head of Roche Sequencing Solutions.  "We are continuing to actively pursue multiple technologies and commercial strategies internally and externally to ensure we address the specific needs of our customers in the clinical diagnostic sequencing market segment."

About Roche

Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people's lives.

Roche is the world's largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible.

Founded in 1896, Roche continues to search for better ways to prevent, diagnose and treat diseases and make a sustainable contribution to society. Twenty-nine medicines developed by Roche are included in the World Health Organization Model Lists of Essential Medicines, among them life-saving antibiotics, antimalarials and cancer medicines. Roche has been recognised as the Group Leader in sustainability within the Pharmaceuticals, Biotechnology & Life Sciences Industry eight years in a row by the Dow Jones Sustainability Indices.

The Roche Group, headquartered in Basel, Switzerland, is active in over 100 countries and in 2015 employed more than 91,700 people worldwide. In 2015, Roche invested CHF 9.3 billion in R&D and posted sales of CHF 48.1 billion. Genentech, in the United States, is a wholly owned member of the Roche Group. Roche is the majority shareholder in Chugai Pharmaceutical, Japan. For more information, please visit www.roche.com. *All trademarks used or mentioned in this release are protected by law. 

For further information, please contact:

Roche Sequencing Solutions
Elizabeth Baxter
Corporate Communications
Mobile: 925.523.8812
elizabeth.baxter@roche.com

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/roche-announces-termination-of-2013-development-commercialization-and-license-agreement-with-pacific-biosciences-300379155.html


'/>"/>
SOURCE Roche
Copyright©2016 PR Newswire.
All rights reserved


Related biology technology :

1. Atomic Force Microscope Leader Park Systems Presents Webinar on Electrochemical Scanned Probes June 16, 2016
2. Say it with Pictures: SPIE Donates Photonics Infographics Books to Rochester Science Museum
3. Roche launches new chromogen for cancer research
4. OHAUS Corporation Unveils New Laboratory Balances and Electrochemistry Meters At Pittcon 2016
5. Atomic Force Microscope Leader Park Systems Presents Electrochemistry Webinar
6. BD Boston Conference Hosted by BD Heads of Shire, Merck, Sanofi, Roche, Biogen, Teva, Nestle, AbbVie on March 9th
7. Cellular Dynamics Announces Collaboration with Roche
8. Global Biologic Therapeutics Market 2015-2019 Key Vendors are Amgen, F. Hoffmann-La Roche, Novo Nordisk & Sanofi
9. Genetic Testing Market Outlook 2015-2020: Key Vendors Influencing the Industry Include Abbott, Roche, Siemens, Illumina, Thermo Fischer Scientific, and Myriad Genetics
10. Roche strengthens oncology translational research pipeline by acquiring CAPP Medical
11. Global HER-2 Positive Breast Cancer Market 2015-2019 - Key Players are Celgene, F. Hoffmann-La Roche, GlaxoSmithKline, Novartis & Sanofi
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2018)... ... September 20, 2018 , ... ... venture. The synergistic combination of Predicine’s GeneRADAR molecular insights platform with Flagship’s ... to empower clinical trials in the immuno-oncology (IO) space. , IO therapies ...
(Date:9/13/2018)... ... September 13, 2018 , ... Asymmetrex’s director, ... we would have gotten in medicine, if we didn’t have the means to measure ... treat patients?” His answer, “Nowhere! And that is what’s holding up progress in ...
(Date:9/7/2018)... ... September 05, 2018 , ... Now available on live stream, the ... on Sept. 19, 2018. With a panel of industry leaders from Harvard, Cornell, RPI, ... reveal industry insights from experts in the field. Register today to be a ...
(Date:9/1/2018)... , ... August 31, 2018 , ... ... results of the impact of a proprietary biofield energy treated nutraceutical supplement used ... biomarkers for immune function response and blood, as well as, organ-specific inflammation. The ...
Breaking Biology Technology:
(Date:8/23/2018)... (PRWEB) , ... August 22, 2018 , ... ... release of LimitLIS® 4.0, the latest version of its rapidly growing cloud-based laboratory ... LimitLIS® Toxicology Edition, as well as the company’s triple digit growth throughout 2018, ...
(Date:8/21/2018)... ... August 20, 2018 , ... ... are many challenges to consider. Designers must ensure what is designed can be ... will explore some best practices in flow path design with specific focus on ...
(Date:8/21/2018)... ... August 21, 2018 , ... Whether it ... Labs is dedicated to offering customers a successful experience. When browsing the ... seamless transition between products, with relevant details such as technical manuals, application notes, ...
Breaking Biology News(10 mins):